Joseph Marks - 16 Jun 2023 Form 4 Insider Report for Augmedix, Inc.

Role: Director
Signature: /s/ Paul Ginocchio, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 16 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 16 Jun 2023, 17:48:50 UTC
Previous filing: 21 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUGX	Common Stock	Options Exercise		+52,632			52,632	16 Jun 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AUGX	Restricted Stock Units	Options Exercise	$0	-52,632	-100%	$0.000000^*	0	16 Jun 2023	Common Stock	52,632		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
F2	On June 16, 2022 (the "Grant Date"), the reporting person was granted 52,632 RSUs which vested in full on the one-year anniversary of the Grant Date.